共 208 条
[1]
Kaul A(2016)Systemic lupus erythematosus Nat Rev Dis Primers 2 16039-64
[2]
Gordon C(2010)The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide Ann Rheum Dis 69 61-1621
[3]
Crow MK(2021)2021 DORIS definition of remission in SLE: final recommendations from an international task force Lupus Sci Med 8 e000538-1274
[4]
Touma Z(2016)Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) Ann Rheum Dis 75 1615-327
[5]
Urowitz MB(2010)European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies Ann Rheum Dis 69 1269-157
[6]
van Vollenhoven R(2000)Endpoints: consensus recommendations from OMERACT IV Lupus 9 322-741
[7]
Ruiz-Irastorza G(2022)Treat-to-target in systemic lupus erythematosus: advancing towards its implementation Nat Rev Rheumatol 18 146-3139
[8]
Hughes G(2019)A novel system to categorize the symptoms of systemic lupus erythematosus arthritis Care Res 71 735-e45
[9]
Houssiau FA(2000)SF-36 health survey update Spine 25 3130-979
[10]
Vasconcelos C(2018)The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults Rheumatology 57 e1-1276